Detalhe da pesquisa
1.
Factors Influencing the Decision of Individuals with Breast Cancer to Join an Exercise Oncology Trial.
J Cancer Educ
; 39(3): 244-252, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418705
2.
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab.
Oncologist
; 28(9): e712-e722, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37094996
3.
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
J Urol
; 207(5): 1020-1028, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978211
4.
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
Acta Oncol
; 61(6): 705-713, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435129
5.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
JAMA
; 327(20): 1963-1973, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608580
6.
The Cardiologist's Role in the Management of Patients with a Genitourinary Cancer.
Isr Med Assoc J
; 24(3): 175-178, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347931
7.
The Hidden Curriculum in Postgraduate Medical Education: a Commentary.
J Cancer Educ
; 36(2): 435-437, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32592035
8.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 21(12): 1574-1588, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971005
9.
Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.
J Urol
; 203(6): 1109-1116, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899651
10.
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?
Oncologist
; 24(11): 1405-1409, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31315962
11.
Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists.
Breast J
; 25(6): 1222-1224, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264272
12.
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial.
Lancet Oncol
; 18(4): 473-485, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283282
13.
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32.
Breast Cancer Res Treat
; 164(2): 371-378, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447237
14.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
N Engl J Med
; 368(2): 138-48, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23228172
15.
A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
Ann Surg Oncol
; 23(10): 3354-64, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342830
16.
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
Prostate
; 75(8): 836-44, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683285
17.
Strategies for Maintaining Educational Standards in Medical Oncology Residency Training in the Era of COVID-19: Experience from a Canadian Cancer Centre.
J Cancer Educ
; 35(6): 1068-1069, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970302
18.
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer.
Invest New Drugs
; 32(4): 746-52, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24671507
19.
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.
Invest New Drugs
; 32(5): 1005-16, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788563
20.
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.
Lancet Oncol
; 14(8): 769-76, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706985